Tag: Biologics License Application (BLA)

Viaskin Peanut

DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy

News Wire -
"This submission represents a significant step forward for those families living with peanut allergy."
AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Dave Bloom -
Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
AR101

Aimmune to Submit FDA Application for Peanut OIT Candidate by End...

Dave Bloom -
If approved, AR101 could be offered as the first FDA approved OIT therapy for peanut allergy.

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

Dave Bloom -
The Viaskin Peanut patch therapy still has 50:50 chance of approval according to research note.

Connect with Us

34,922FansLike
94FollowersFollow
197FollowersFollow
2,324FollowersFollow
5,211FollowersFollow
37SubscribersSubscribe
SnackSafely.com

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 15 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

© SnackSafely.com Inc. All rights reserved.